TNFerade

GENETIC2 trials

Sponsors

GenVec

Conditions

Esophageal CancerPancreatic Cancer

Phase 2

Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer

CompletedNCT00051480

GenVecEsophageal Cancer

Updated: 2011-05-12

Phase 3

A Study of TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer

CompletedNCT00051467

GenVecPancreatic Cancer

Updated: 2012-02-23